These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24118389)

  • 21. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
    Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid avoidance in renal transplantation.
    Lightner A; Concepcion W; Grimm P
    Curr Opin Organ Transplant; 2011 Oct; 16(5):477-82. PubMed ID: 21844809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic renal allograft failure: clinical overview. The Leuven Collaborative Group for Transplantation.
    Peeters J; Roels L; Vanrenterghem Y
    Kidney Int Suppl; 1995 Dec; 52():S97-101. PubMed ID: 8587294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional variation in kidney transplant outcomes: trends over time.
    Chakkera HA; Chertow GM; O'Hare AM; Amend WJ; Gonwa TA
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):152-9. PubMed ID: 18922989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for rejection of renal transplant allografts refractory to medical immunosuppression.
    Wahl AO; Small W; Dixler I; Strom S; Rademaker A; Leventhal J; Abecassis MM
    Am J Clin Oncol; 2006 Dec; 29(6):551-4. PubMed ID: 17148990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intolerance syndrome in failed renal allografts: incidence and efficacy of percutaneous embolization.
    Delgado P; Diaz F; Gonzalez A; Sanchez E; Gutierrez P; Hernandez D; Torres A; Lorenzo V
    Am J Kidney Dis; 2005 Aug; 46(2):339-44. PubMed ID: 16112054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
    Kreis HA; Ponticelli C
    Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V; Rice JC; Carson RW; Gugliuzza KK; Fish JC
    Clin Transplant; 1996 Apr; 10(2):203-8. PubMed ID: 8664520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic allograft nephropathy].
    Klimek D; Chudek J
    Pol Merkur Lekarski; 2001 Jul; 11(61):95-8. PubMed ID: 11579843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The failed renal transplant: in or out?
    Bennett WM
    Semin Dial; 2005; 18(3):188-9. PubMed ID: 15934960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patients.
    Grinyo JM; Saval N; Campistol JM;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3750-5. PubMed ID: 21474575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Campath induction for kidney transplantation: report of 297 cases.
    Ortiz J; Palma-Vargas J; Wright F; Bingaman A; Agha I; Rosenblatt S; Foster P
    Transplantation; 2008 Jun; 85(11):1550-6. PubMed ID: 18551058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.
    Säemann MD; Sunder-Plassmann G
    Transpl Immunol; 2008 Nov; 20(1-2):14-20. PubMed ID: 18804533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the addition of maintenance steroids to a rapid steroid discontinuation immunosuppressive protocol following acute renal transplant rejection.
    Arora S; Marcus RJ; Dikkala S; Sureshkumar KK
    Exp Clin Transplant; 2009 Dec; 7(4):233-6. PubMed ID: 20353373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.